# FDA Inspection 1007877 - Dexcel Pharma Ltd. - February 16, 2017

Source: https://www.keypedia.com/records/fda_inspections/dexcel-pharma-ltd/cfef2ab3-f0eb-4b7b-bb92-e3ec84498568
Source feed: FDA_Inspections

> FDA Inspection 1007877 for Dexcel Pharma Ltd. on February 16, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1007877
- Company Name: Dexcel Pharma Ltd.
- Inspection Date: 2017-02-16
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1195631 - 2022-12-14](https://www.keypedia.com/records/fda_inspections/dexcel-pharma-ltd/efb25b80-58ae-46af-9e0d-ba5479760b07)
- [FDA Inspection 1097285 - 2019-07-24](https://www.keypedia.com/records/fda_inspections/dexcel-pharma-ltd/22fbe152-1d95-4a72-a2b9-b19e079e4ac5)
- [FDA Inspection 836838 - 2013-06-05](https://www.keypedia.com/records/fda_inspections/dexcel-pharma-ltd/c049dbf1-b63b-4c05-911e-fd5a04b2dc6a)

Company: https://www.keypedia.com/companies/dexcel-pharma-ltd/4ec8aec2-8e4a-4886-8b52-f6d83c19e0c8

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c